Sachdev Amit Insider Trading
Get the latest insider transactions of Sachdev Amit. Sachdev Amit is EVP, Chief Patient Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, CRO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and EVP, Policy, Access & Value in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, Corp Affairs & Pub Policy in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and SVP, Public Policy,Gov Affairs in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR). Discover the current value of Sachdev Amit shares.
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE 02139MA
Sachdev Amit is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
VRTX | VERTEX PHARMACEUTICALS INC / MA | EVP, Chief Patient Officer, EVP, CRO, EVP, Policy, Access & Value, SVP, Corp Affairs & Pub Policy, SVP, Public Policy,Gov Affairs | 44,017 | 3,822,436.28 |
EIGR | Eiger BioPharmaceuticals, Inc. | Director | 10,000 | 116,000.00 |
Insider Trading Transactions of Sachdev Amit
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 3,884 | 336,044 | 44,017 |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 215.58 | 2,346 | 505,751 | 41,671 |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 216.67 | 1,338 | 289,904 | 40,333 |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 217.69 | 200 | 43,538 | 40,133 |
Apr 29 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 3,884 | 336,044 | 0 |
Mar 15 2021 | EIGR | Eiger BioPharmaceuticals, ... | Sachdev Amit | Director | Buy | 0.00 | 5,000 | 0 | 10,000 |
Mar 15 2021 | EIGR | Eiger BioPharmaceuticals, ... | Sachdev Amit | Director | Option Exercise | 9.99 | 10,000 | 99,900 | 10,000 |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 217.57 | 2,946 | 640,961 | 43,719 |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 211.56 | 922 | 195,058 | 42,797 |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 213.30 | 1,460 | 311,418 | 41,337 |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 214.19 | 668 | 143,079 | 40,669 |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 215.56 | 336 | 72,428 | 40,333 |
Feb 26 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 216.62 | 200 | 43,324 | 40,133 |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 211.75 | 7,613 | 1,612,053 | 55,929 |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 210.00 | 1,164 | 244,440 | 54,765 |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 211.36 | 1,500 | 317,040 | 53,265 |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 212.15 | 5,800 | 1,230,470 | 47,465 |
Feb 19 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 213.02 | 800 | 170,416 | 46,665 |
Feb 12 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 214.16 | 2,421 | 518,481 | 68,002 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 0.00 | 3,391 | 0 | 7,368 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 10,126 | 0 | 48,472 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 10,324 | 0 | 58,796 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 11,627 | 0 | 70,423 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 0.00 | 3,391 | 0 | 7,368 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 10,126 | 0 | 48,472 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 10,324 | 0 | 58,796 |
Feb 05 2021 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 11,627 | 0 | 70,423 |
Nov 18 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 222.50 | 12 | 2,670 | 35,133 |
Nov 18 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 223.76 | 22 | 4,923 | 35,111 |
Nov 18 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 224.44 | 8 | 1,796 | 35,103 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,941 | 167,935 | 37,044 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 276.96 | 500 | 138,480 | 36,544 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 278.25 | 690 | 191,993 | 35,854 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 279.18 | 751 | 209,664 | 35,103 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,941 | 167,935 | 3,884 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,941 | 167,935 | 37,044 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 276.96 | 500 | 138,480 | 36,544 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 278.25 | 690 | 191,993 | 35,854 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 279.18 | 751 | 209,664 | 35,103 |
Aug 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,941 | 167,935 | 3,884 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 131.89 | 10,665 | 1,406,607 | 45,768 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 276.25 | 800 | 221,000 | 44,968 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 277.38 | 201 | 55,753 | 44,767 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 279.67 | 655 | 183,184 | 44,112 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 280.77 | 1,817 | 510,159 | 42,295 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 281.74 | 1,398 | 393,873 | 40,897 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 282.89 | 913 | 258,279 | 39,984 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 283.98 | 1,100 | 312,378 | 38,884 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 285.15 | 2,314 | 659,837 | 36,570 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 285.94 | 1,367 | 390,880 | 35,203 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 286.72 | 100 | 28,672 | 35,103 |
May 13 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 131.89 | 10,665 | 1,406,607 | 0 |
May 08 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 131.89 | 669 | 88,234 | 35,772 |
May 08 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 275.28 | 669 | 184,162 | 35,103 |
May 08 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 131.89 | 669 | 88,234 | 10,665 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 32,500 | 3,547,050 | 67,603 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 32,500 | 3,547,050 | 67,603 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 131.89 | 9,310 | 1,227,896 | 76,913 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 131.89 | 9,310 | 1,227,896 | 76,913 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,942 | 168,022 | 78,855 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,942 | 168,022 | 78,855 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 258.59 | 1,400 | 362,026 | 77,455 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 258.59 | 1,400 | 362,026 | 77,455 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 259.63 | 6,223 | 1,615,677 | 71,232 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 259.63 | 6,223 | 1,615,677 | 71,232 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 260.48 | 8,383 | 2,183,604 | 62,849 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 260.48 | 8,383 | 2,183,604 | 62,849 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 261.68 | 4,395 | 1,150,084 | 58,454 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 261.68 | 4,395 | 1,150,084 | 58,454 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 262.69 | 9,447 | 2,481,632 | 49,007 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 262.69 | 9,447 | 2,481,632 | 49,007 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 263.58 | 964 | 254,091 | 48,043 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 263.58 | 964 | 254,091 | 48,043 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 264.92 | 12,940 | 3,428,065 | 35,103 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 264.92 | 12,940 | 3,428,065 | 35,103 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 131.89 | 13,356 | 1,761,523 | 48,459 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 131.89 | 13,356 | 1,761,523 | 48,459 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 265.72 | 100 | 26,572 | 48,359 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 265.72 | 100 | 26,572 | 48,359 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 267.34 | 300 | 80,202 | 48,059 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 267.34 | 300 | 80,202 | 48,059 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 269.08 | 700 | 188,356 | 47,359 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 269.08 | 700 | 188,356 | 47,359 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 270.01 | 11,553 | 3,119,426 | 35,806 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 270.01 | 11,553 | 3,119,426 | 35,806 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 271.09 | 100 | 27,109 | 35,706 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 271.09 | 100 | 27,109 | 35,706 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 272.58 | 403 | 109,850 | 35,303 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 272.58 | 403 | 109,850 | 35,303 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 273.59 | 200 | 54,718 | 35,103 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 273.59 | 200 | 54,718 | 35,103 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 32,500 | 3,547,050 | 0 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 32,500 | 3,547,050 | 0 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 131.89 | 9,310 | 1,227,896 | 24,690 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 131.89 | 9,310 | 1,227,896 | 24,690 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,942 | 168,022 | 5,825 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,942 | 168,022 | 5,825 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 131.89 | 13,356 | 1,761,523 | 11,334 |
May 06 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 131.89 | 13,356 | 1,761,523 | 11,334 |
Mar 13 2020 | EIGR | Eiger BioPharmaceuticals, ... | Sachdev Amit | Director | Buy | 0.00 | 5,000 | 0 | 5,000 |
Mar 13 2020 | EIGR | Eiger BioPharmaceuticals, ... | Sachdev Amit | Director | Option Exercise | 5.60 | 10,000 | 56,000 | 10,000 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 239.23 | 3,156 | 755,010 | 36,291 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 230.00 | 953 | 219,190 | 35,338 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 230.98 | 270 | 62,365 | 35,068 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 232.62 | 450 | 104,679 | 34,618 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 233.18 | 90 | 20,986 | 34,528 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 234.56 | 533 | 125,020 | 33,995 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 235.75 | 360 | 84,870 | 33,635 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 236.63 | 180 | 42,593 | 33,455 |
Feb 26 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 238.33 | 540 | 128,698 | 32,915 |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 241.50 | 3,262 | 787,773 | 42,936 |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 242.04 | 720 | 174,269 | 42,216 |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 242.85 | 1,260 | 305,991 | 40,956 |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 244.08 | 540 | 131,803 | 40,416 |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 245.15 | 720 | 176,508 | 39,696 |
Feb 19 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 245.82 | 249 | 61,209 | 39,447 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 240.95 | 12,215 | 2,943,204 | 59,268 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 243.53 | 1,000 | 243,530 | 58,268 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 245.05 | 3,426 | 839,541 | 54,842 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 245.99 | 4,320 | 1,062,677 | 50,522 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 246.88 | 1,821 | 449,568 | 48,701 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 247.98 | 2,103 | 521,502 | 46,598 |
Feb 12 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 248.73 | 400 | 99,492 | 46,198 |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 15,170 | 0 | 51,360 |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 9,800 | 0 | 61,160 |
Feb 07 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 0.00 | 10,323 | 0 | 71,483 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 91.05 | 2,156 | 196,304 | 38,346 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,941 | 167,935 | 40,287 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 228.89 | 500 | 114,445 | 39,787 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 230.07 | 714 | 164,270 | 39,073 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 231.25 | 1,306 | 302,013 | 37,767 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 231.92 | 1,177 | 272,970 | 36,590 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 232.87 | 400 | 93,148 | 36,190 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 91.05 | 2,156 | 196,304 | 0 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,941 | 167,935 | 7,767 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 91.05 | 2,156 | 196,304 | 38,346 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,941 | 167,935 | 40,287 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 228.89 | 500 | 114,445 | 39,787 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 230.07 | 714 | 164,270 | 39,073 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 231.25 | 1,306 | 302,013 | 37,767 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 231.92 | 1,177 | 272,970 | 36,590 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 232.87 | 400 | 93,148 | 36,190 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 91.05 | 2,156 | 196,304 | 0 |
Feb 05 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,941 | 167,935 | 7,767 |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 5,000 | 545,700 | 41,190 |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 235.00 | 5,000 | 1,175,000 | 36,190 |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 5,000 | 545,700 | 32,500 |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 5,000 | 545,700 | 41,190 |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 230.00 | 5,000 | 1,150,000 | 36,190 |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 5,000 | 545,700 | 37,500 |
Dec 10 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 5,000 | 545,700 | 38,416 |
Dec 10 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 225.00 | 5,000 | 1,125,000 | 33,416 |
Dec 10 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 5,000 | 545,700 | 42,500 |
Dec 10 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 5,000 | 545,700 | 38,416 |
Dec 10 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 225.00 | 5,000 | 1,125,000 | 33,416 |
Dec 10 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 5,000 | 545,700 | 42,500 |
Nov 26 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 5,000 | 545,700 | 38,416 |
Nov 26 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 220.00 | 5,000 | 1,100,000 | 33,416 |
Nov 26 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 5,000 | 545,700 | 47,500 |
Nov 21 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 109.14 | 5,000 | 545,700 | 38,416 |
Nov 21 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 215.00 | 5,000 | 1,075,000 | 33,416 |
Nov 21 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 109.14 | 5,000 | 545,700 | 52,500 |
Nov 19 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 205.95 | 57 | 11,739 | 33,416 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 91.05 | 2,155 | 196,213 | 35,571 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 1,942 | 168,022 | 37,513 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 199.77 | 500 | 99,885 | 37,013 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 200.12 | 2,497 | 499,700 | 34,516 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 201.10 | 1,100 | 221,210 | 33,416 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 91.05 | 2,155 | 196,213 | 2,156 |
Nov 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 1,942 | 168,022 | 9,708 |
Oct 29 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 91.05 | 4,311 | 392,517 | 37,727 |
Oct 29 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 195.01 | 4,311 | 840,688 | 33,416 |
Oct 29 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 91.05 | 4,311 | 392,517 | 4,311 |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Buy | 86.52 | 3,883 | 335,957 | 37,299 |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Sell | 190.27 | 3,883 | 738,818 | 33,416 |
Oct 24 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, Chief Patient Of ... | Option Exercise | 86.52 | 3,883 | 335,957 | 11,650 |
May 30 2019 | EIGR | Eiger BioPharmaceuticals, ... | Sachdev Amit | Director | Option Exercise | 11.13 | 25,000 | 278,250 | 25,000 |
Feb 08 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 0.00 | 17,298 | 0 | 55,335 |
Feb 08 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 0.00 | 10,126 | 0 | 65,461 |
Feb 08 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 0.00 | 9,799 | 0 | 75,260 |
Feb 08 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 187.53 | 25,026 | 4,693,126 | 25,026 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 86.52 | 1,942 | 168,022 | 48,604 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 186.57 | 1,200 | 223,884 | 47,404 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 187.35 | 742 | 139,014 | 46,662 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 91.05 | 2,155 | 196,213 | 48,817 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 186.52 | 1,120 | 208,902 | 47,697 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 187.23 | 1,035 | 193,783 | 46,662 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 186.55 | 5,000 | 932,750 | 41,662 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 187.30 | 3,625 | 678,963 | 38,037 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 86.52 | 1,942 | 168,022 | 15,533 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 91.05 | 2,155 | 196,213 | 8,622 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 86.52 | 1,942 | 168,022 | 48,604 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 186.57 | 1,200 | 223,884 | 47,404 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 187.35 | 742 | 139,014 | 46,662 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 91.05 | 2,155 | 196,213 | 48,817 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 186.52 | 1,120 | 208,902 | 47,697 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 187.23 | 1,035 | 193,783 | 46,662 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 186.55 | 5,000 | 932,750 | 41,662 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 187.30 | 3,625 | 678,963 | 38,037 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 86.52 | 1,942 | 168,022 | 15,533 |
Feb 06 2019 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 91.05 | 2,155 | 196,213 | 8,622 |
Nov 19 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 163.75 | 61 | 9,989 | 46,662 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 91.05 | 2,155 | 196,213 | 48,817 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 171.93 | 600 | 103,158 | 48,217 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 172.81 | 1,255 | 216,877 | 46,962 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 173.35 | 100 | 17,335 | 46,862 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 175.31 | 100 | 17,531 | 46,762 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 176.04 | 100 | 17,604 | 46,662 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 86.52 | 1,941 | 167,935 | 48,603 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 172.70 | 300 | 51,810 | 48,303 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 173.74 | 1,213 | 210,747 | 47,090 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 174.41 | 428 | 74,647 | 46,662 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 91.05 | 2,155 | 196,213 | 10,777 |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 86.52 | 1,941 | 167,935 | 17,475 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 91.05 | 2,155 | 196,213 | 48,817 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 175.06 | 700 | 122,542 | 48,117 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 175.88 | 400 | 70,352 | 47,717 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 176.95 | 400 | 70,780 | 47,317 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 178.49 | 355 | 63,364 | 46,962 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 179.38 | 300 | 53,814 | 46,662 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 86.52 | 1,942 | 168,022 | 48,604 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 174.50 | 1,142 | 199,279 | 47,462 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 175.86 | 700 | 123,102 | 46,762 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 176.69 | 100 | 17,669 | 46,662 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 91.05 | 2,155 | 196,213 | 12,932 |
Aug 06 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 86.52 | 1,942 | 168,022 | 19,416 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 96.87 | 12,031 | 1,165,443 | 58,693 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 180.00 | 12,031 | 2,165,580 | 46,662 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 96.87 | 1,719 | 166,520 | 48,381 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 180.14 | 1,500 | 270,210 | 46,881 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 181.88 | 219 | 39,832 | 46,662 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 96.87 | 12,031 | 1,165,443 | 1,719 |
Jul 17 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 96.87 | 1,719 | 166,520 | 0 |
May 16 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 155.78 | 83 | 12,930 | 46,662 |
Mar 12 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 96.87 | 13,750 | 1,331,963 | 60,412 |
Mar 12 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 175.00 | 13,750 | 2,406,250 | 46,662 |
Mar 12 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 96.87 | 13,750 | 1,331,963 | 13,750 |
Feb 28 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 91.05 | 2,155 | 196,213 | 48,817 |
Feb 28 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 170.00 | 2,155 | 366,350 | 46,662 |
Feb 28 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 91.05 | 2,155 | 196,213 | 17,242 |
Feb 14 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 149.22 | 4,500 | 671,490 | 59,958 |
Feb 14 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 150.44 | 3,200 | 481,408 | 56,758 |
Feb 14 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 151.22 | 7,296 | 1,103,301 | 49,462 |
Feb 14 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 152.26 | 1,100 | 167,486 | 48,362 |
Feb 14 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 153.25 | 1,400 | 214,550 | 46,962 |
Feb 14 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Sell | 153.92 | 300 | 46,176 | 46,662 |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 0.00 | 15,170 | 0 | 54,333 |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 0.00 | 10,125 | 0 | 64,458 |
Feb 08 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Option Exercise | 155.57 | 23,479 | 3,652,628 | 23,479 |
Feb 07 2018 | VRTX | VERTEX PHARMACEUTICALS IN ... | Sachdev Amit | EVP, CRO | Buy | 86.52 | 1,942 | 168,022 | 41,105 |